Background: The progressive scarring observed in cicatricial pemphigoid (CP) is still partially unexplained but recently the release of soluble fibrogenic factors by inflammatory infiltrating cells has been considered as pathogenically relevant. In the present study we evaluated the expression of mRNA for IL-4, IL-5, TGF-beta1, IFN-gamma in CP in comparison to bullous pemphigoid (BP) patients, investigating the role of cytokine profile as possible cause of the different disease evolution.

Methods: Biopsies from patients with oral (n = 10), preputial (n = 3) and cutaneous (n = 1) CP were studied by in situ hybridisation performing a new amplification system based on biotinyl-tyramide. As control, four patients affected by BP were also examined, together with healthy tissue from two CP and two BP patients, respectively.

Results: In CP IL-4 mRNA expression was present in 4 out of 14 cases analysed. IL-5 was detected in 12 CP biopsies. TGF-beta1 and IFN-gamma mRNAs were identified in 9 and 11 CP cases, respectively. In BP, IL-4 hybridisation signal could not be observed in any of the cases. By contrast IL-5, TGF-beta1 and IFN-gamma mRNA analyses were positive in all BP cases. Healthy specimens did not show any expression for IL-4, IL-5 and IFN-gamma, while a poor staining for TGF-beta was found in epithelium and subjunctional areas.

Conclusions: Our results highlight the presence of a mixed cytokine pattern in the cellular infiltrate of both blistering diseases, with a corresponding increase of Th2-like activity in fully developed lesions, irrespective of the different sites involved. In addition, the constant presence of TGF-beta1 mRNA in the different lesional phases of CP, and its overlapping expression in BP suggest that the involvement of additional factors is responsible for the scarring course typical of CP.

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0714.2003.00028.xDOI Listing

Publication Analysis

Top Keywords

tgf-beta1 ifn-gamma
12
cytokine profile
8
cicatricial pemphigoid
8
il-4 il-5
8
il-5 tgf-beta1
8
profile supposed
4
supposed contribution
4
contribution scarring
4
scarring cicatricial
4
pemphigoid background
4

Similar Publications

During the late laying period, the intestinal barrier of laying hens is susceptible to damage, resulting in enteric infections and even systemic inflammatory responses, posing a major challenge for the poultry industry. Therefore, it is crucial to investigate methods for addressing intestinal inflammation in late laying hens. In order to maximize the production potential of egg laying chickens, farmers usually use various feed additives to prevent damage to the intestinal barrier.

View Article and Find Full Text PDF

Background: Previous studies primarily focused on the effects of ALT and virology, but there is a lack of research on the correlations of HBcrAg and pgRNA, two novel virologic markers, with immunological parameters in pregnant women with CHB undergoing prophylactic antiviral intervention.

Methods: We conducted a retrospective cohort study involving 28 HBeAg-positive pregnant women with CHB undergoing prophylactic antiviral intervention. Clinical data, virological markers (HBV DNA, HBsAg, HBeAg, HBcrAg and pgRNA) and 28 cytokines were detected at three time points: 24-28 weeks gestation (before prophylactic antiviral intervention), near birth and within 3 months postpartum.

View Article and Find Full Text PDF
Article Synopsis
  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease where hyper-activated B cells produce autoantibodies, causing symptoms.
  • Research found that naïve mesenchymal stem cells (MSCs) inhibit T cell activity but not B cell IgM production, leading to a study on how to enhance MSC function.
  • Treatment with ingenol-3-angelate (I3A) primes MSCs to inhibit B cells through the secretion of TGF-β1, showing improved effectiveness in alleviating SLE symptoms in mice.
View Article and Find Full Text PDF

Prostaglandin D2 (PGD2) signals via the DP1 and DP2 receptors. In Phase II trials, DP2 antagonism decreased airway inflammation and airway smooth muscle (ASM) area in moderate-to-severe asthma patients. However, in Phase III, DP2 antagonism failed to lower the rate of exacerbations, and DP2 as a target was shelved.

View Article and Find Full Text PDF
Article Synopsis
  • ABAT, an enzyme involved in GABA metabolism, is underexpressed in liver cancer, correlating with worse patient survival and driving tumor growth and invasion.
  • * Overexpression of ABAT reduces GABA levels while increasing immune regulatory factors like IL-10 and TGF-β1, enhancing the activity of regulatory T cells (Tregs).
  • * Inhibiting ABAT reduces the effectiveness of CD8+ T cells in attacking tumors, suggesting that the ABAT/GABA axis plays a critical role in immune regulation within liver cancer.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!